Author:
Takuwa Teruhisa,Hasegawa Seiki
Publisher
Springer Science and Business Media LLC
Reference63 articles.
1. Aziz T, Jilaihawi A, Prakash D. The management of malignant pleural mesothelioma; single centre experience in 10 years. Eur J Cardiothorac Surg. 2002;22:298–305.
2. Rusch V, Baldini EH, Bueno R, De Perrot M, Flores R, Hasegawa S, et al. The role of surgical cytoreduction in the treatment of malignant pleural mesothelioma: Meeting Summary of the International Mesothelioma Interest Group Congress, September 11–14, 2012, Boston, Mass. J Thora Cardiov Surg. 2013;145:909–10.
3. Sugarbaker DJ. Macroscopic complete resection: the goal of primary surgery in multimodality therapy for pleural mesothelioma. Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer. 2006;1:175–6.
4. Cameron RB. Extrapleural pneumonectomy is the preferred surgical management in the multimodality therapy of pleural mesothelioma: con argument. Ann Surg Oncol. 2007;14:1249–53.
5. Rice D, Rusch VW, Pass H, Asamura H, Nakano T, Edwards J, et al. Recommendations for Uniform Definitions of Surgical Techniques for Malignant Pleural Mesothelioma. A Consensus Report of the International Association for the Study of Lung Cancer International Staging Committee and the International Mesothelioma Interest Group. Journal of thoracic oncology: official publication of the International Association for the Study of. Lung Cancer. 2011;6:1304–12.
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献